Answers are grounded in this paper and cite their sources.
Previous randomized controlled trials have demonstrated benefit from remote symptom monitoring (RSM) with electronic patient-reported outcomes. However, the racial diversity of enrolled patients was low and did not reflect the real-world racial proportions for individuals with cancer.
No takes yet. Share an insight, caveat, or question.
Rocque et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: